BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4226874)

  • 1. [Diagnostic and prognostic significance of changes in adenosintriphosphatase activity of erythrocytes in hemolytic disease of the newborn].
    Osinov AI
    Vopr Okhr Materin Det; 1966 Feb; 11(2):19-23. PubMed ID: 4226874
    [No Abstract]   [Full Text] [Related]  

  • 2. [Diagnostic and prognostic significance of erythrocyte adenosine triphosphatase activity changes in hemolytic disease in the newborn].
    Osipov AI
    Vopr Okhr Materin Det; 1969 Feb; 14(2):90. PubMed ID: 4241957
    [No Abstract]   [Full Text] [Related]  

  • 3. Study of adenosintriphosphatase activity of erythrocytes in newborns with hemolytic disease.
    Ossipov AI
    Indian Pediatr; 1972 Jul; 9(7):408-10. PubMed ID: 4265408
    [No Abstract]   [Full Text] [Related]  

  • 4. [Enzymatic defects of erythrocytes and hemolysis in the newborn].
    Vetrella M; Pierro M
    Pediatria (Napoli); 1971 Dec; 79(4):517-26. PubMed ID: 4401200
    [No Abstract]   [Full Text] [Related]  

  • 5. [Changes in 6-phosphogluconate dehydrogenase activity of erythrocytes at various periods of childhood and in hemolytic disease of the newborn].
    Kovalev IuR
    Vopr Okhr Materin Det; 1971 Mar; 16(3):87-8. PubMed ID: 5104537
    [No Abstract]   [Full Text] [Related]  

  • 6. [New prognostic evaluation of fetal hemolytic disease].
    Mares J
    Cesk Gynekol; 1967 Aug; 32(6):477-80. PubMed ID: 4967171
    [No Abstract]   [Full Text] [Related]  

  • 7. [Study of the acetylcholinesterase activity of the erythrocytes in hemolytic disease of the newborn].
    Sirchia G; Ferrone S; Milani R; Masera G
    Haematol Lat; 1966; 9(3):215-20. PubMed ID: 4966138
    [No Abstract]   [Full Text] [Related]  

  • 8. [Significance of the bilirubin-binding properties of blood proteins for the prognosis of hemolytic disease of the newborn].
    Punchenok NA
    Vopr Okhr Materin Det; 1975 Aug; 20(8):15-8. PubMed ID: 1237190
    [No Abstract]   [Full Text] [Related]  

  • 9. Monocyte monolayer assay (MMA)--an efficient method for predicting the clinical significance of alloantibodies and the severity of hemolytic disease of the newborn.
    Garratty G
    Beitr Infusionsther; 1988; 21():236-9. PubMed ID: 2462981
    [No Abstract]   [Full Text] [Related]  

  • 10. [Erythrocyte acetylcholinesterase activity in newborn infants with hemolytic disease due to ABO incompatibility].
    Sbraccia C; Carapella de Luca E; Bonanni V
    Minerva Pediatr; 1965 Oct; 17(29):1527-31. PubMed ID: 5892925
    [No Abstract]   [Full Text] [Related]  

  • 11. [Activity of malate dehydrogenase in plasma and erythrocytes in hemolytic disease of the newborn].
    Borisova TZ
    Vopr Okhr Materin Det; 1970 Jan; 15(1):17-9. PubMed ID: 5465828
    [No Abstract]   [Full Text] [Related]  

  • 12. [Value of the use of erythrocytes from the newborn for the demonstration of anti-A and anti-B immune antibodies responsible for ABO hemolytic disease of the newborn].
    Ducos J; Bierme RS; Ohayon E; Marty Y
    Transfusion (Paris); 1967; 10(2):133-40. PubMed ID: 6070701
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prenatal prognosis of the hemolytic disease of the newborn].
    Polácek K; Zwinger A; Vedra B
    Cesk Gynekol; 1972 Jun; 37(6):423-7. PubMed ID: 4626308
    [No Abstract]   [Full Text] [Related]  

  • 14. [Serological testing methods and their results in the early diagnosis of hemolytic disease of the newborn].
    Berge H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 92(3):359-63. PubMed ID: 4193014
    [No Abstract]   [Full Text] [Related]  

  • 15. [The activity of glucose-6-phosphate dehydrogenase and of transketolase in the erythrocytes in hemolytic disease of the newborn].
    Kovalev IuR
    Vopr Okhr Materin Det; 1968 Jan; 13(1):9-13. PubMed ID: 4976082
    [No Abstract]   [Full Text] [Related]  

  • 16. [Behavior of erythrocytic acetylcholinesterase activity in the hemolytic disease of the newborn due to ABO incompatibility in relation to erythrocyte age].
    Gerlini G; Ottaviano S; Sbraccia C; Carapella E; Bonanni V
    Riv Clin Pediatr; 1968; 81(5):742-5. PubMed ID: 5754265
    [No Abstract]   [Full Text] [Related]  

  • 17. [Activity of certain enzymes in erythrocytes from neonatal and maternal blood in cases of normal deliveries and in hemolytic disease].
    Jasiewicz A
    Ginekol Pol; 1970 Nov; 41(11):1189-93. PubMed ID: 5494875
    [No Abstract]   [Full Text] [Related]  

  • 18. [Prenatal prognosis of hemolytic disease in newborn infants. IV. Familial differences in the development of isoimmunization].
    Polácek K; Kadlecková M
    Cesk Gynekol; 1965 Dec; 30(10):735-9. PubMed ID: 5865666
    [No Abstract]   [Full Text] [Related]  

  • 19. [The prenatal prognosis of hemolytic disease in newborn infants. VI. Indication for the induction of premature labor and results achieved].
    Polácek K
    Cesk Gynekol; 1966 Aug; 31(6):524-8. PubMed ID: 5925824
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical aspects of Rh incompatibility. II. Discrepancy between high anti-D titer and incipient mild hemolytic disease of the newborn].
    Gmyrek D; Reitzig C; Schubert S; Syllm-Rapoport I
    Dtsch Gesundheitsw; 1971 Apr; 26(15):687-92. PubMed ID: 5103567
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.